SCHEMBL8237142

SCHEMBL8237142

CC(=O)c1ccnc2[nH]c(-c3ccoc3)nc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 4/20 0.41
TOP2A P11388 1/20 0.39
ADORA1 P30542 3/20 0.38
TMIGD3 P0DMS9 2/20 0.38
ADORA3 P0DMS8 2/20 0.38
ADORA2A P29274 2/20 0.38
ADORA2B P29275 2/20 0.38
IKBKE Q14164 1/20 0.36
TBK1 Q9UHD2 1/20 0.36
LRRK2 Q5S007 6/20 0.34
AURKA O14965 1/20 0.34
MAP4K4 O95819 1/20 0.34
PAK4 O96013 1/20 0.34
ABL1 P00519 1/20 0.34
FYN P06241 1/20 0.34
RET P07949 1/20 0.34
LTK P29376 1/20 0.34
KDR P35968 1/20 0.34
MAPK8 P45983 1/20 0.34
CSNK1A1 P48729 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4167033 0.88 GSK3B (0.42) GSK3BTOP2AADORA1TMIGD3
SCHEMBL4144871 0.87 PKN1 (0.47) GSK3BTOP2AADORA1TMIGD3ADORA3
SCHEMBL4161603 0.80 PRMT5 (0.48) IKBKETBK1AURKARETLIMK1
SCHEMBL4158077 0.79 TMIGD3 (0.42) GSK3BADORA1TMIGD3AURKAMAPT
SCHEMBL4156920 0.77 GSK3B (0.59) GSK3BGSK3A
SCHEMBL4148232 0.77 GSK3B (0.55) GSK3B
SCHEMBL4147746 0.75 GSK3B (0.49) GSK3BGSK3A
SCHEMBL4157073 0.75 GSK3B (0.54) GSK3BADORA1ADORA2A
SCHEMBL4165066 0.74 GSK3B (0.57) GSK3B
SCHEMBL4147494 0.74 GSK3B (0.53) GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007083978-A1 IMIDAZOPYRIDINE DERIVATIVES INHIBITING PROTEIN KINASE ACTIVITY, METHOD FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING SAME CRYSTALGENOMICS, INC. (KR) 2007-07-26 WO disclosed